Catheter Precision (VTAK)

Profile

Full Name

Catheter Precision, Inc.

Ticker Symbol

VTAK

Exchange

NYSE American

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

September 27, 2018

Indexes

Not included

Website

http://www.catheterprecision.com

Employees

22

Key Details

Price

$0.33(+0.09%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$420.00K(-4.98% YoY)

Annual EPS

-$6.68(+94.86% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.33
VTAK price is $0.33

30-Day Relative Volume

1.00
VTAK 30-day relative volume is 1.00

Price Performance

Price Today change

+0.09%
VTAK price is up +0.09% today

Price YTD change

-26.6%
VTAK price is down -26.6% since January 1st

Price 1-year change

-32.59%
VTAK price is down -32.59% year-on-year

Price 3-year change

-98.11%
VTAK price is down -98.11% over the past 3 years

Price Range

Price All-time high

$27500.00
VTAK price is currently -100.00% below its historical high of $27500.00

Price 3-year low

$0.24
VTAK price is currently +37.63% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.64M
VTAK market capitalization is $2.64 million

Market cap 3-year change

+133.87%
VTAK market capitalization is up +133.87% over the past 3 years

Market cap All-time high

$25.00M
VTAK market capitalization is currently -89.42% below its historical high of $25.00 million

Market cap sector rank

7.89%
VTAK market capitalization is higher than 7.89% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+956.99%
VTAK shares outstanding is up +956.99% year-on-year

Shares Outstanding 3-Year Change

+12291.02%
VTAK shares outstanding is up +12291.02% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.07
VTAK beta is 1.07

200-day SMA

$0.76
VTAK price is currently -56.67% below its 200-day simple moving average

50-day SMA

$0.36
VTAK price is currently -8.10% below its 50-day simple moving average

RSI

45.26
VTAK 14-day relative strength index is 45.26

Volume

1.00
VTAK 30-day relative volume is 1.00

ATR

$0.04
VTAK average true range is $0.04

10-day Historical Volatility

64.53%
VTAK 10-day historical volatility is 64.53%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$420.00K
VTAK annual revenue is $420.00 thousand

Revenue Analysts estimate

$3.82M
VTAK annual revenue is currently -89.01% lower than the consensus analysts' forecast

Revenue 1-year change

-4.98%
VTAK annual revenue is down -4.98% year-on-year

Revenue Sector rank

8.96%
VTAK annual revenue is higher than 8.96% of companies in Healthcare sector

EPS

EPS

-$6.68
VTAK annual earnings per share is -$6.68

EPS Analysts estimate

-$0.63
VTAK annual earnings per share is currently +960.32% higher than the consensus analysts' forecast

EPS 1-year change

+94.86%
VTAK annual earnings per share is up +94.86% year-on-year

EPS Sector rank

15.36%
VTAK annual earnings per share is higher than 15.36% of companies in Healthcare sector

Profit

Gross profit

$378.00K
VTAK annual gross profit is $378.00 thousand

Gross margin

90.00%
VTAK annual gross profit margin is 90.00%

Operating profit

-$11.24M
VTAK annual operating income is -$11.24 million

Operating margin

-2676.90%
VTAK annual operating profit margin is -2676.90%

Net income

-$16.64M
VTAK annual net profit is -$16.64 million

Net margin

-3962.62%
VTAK annual net profit margin is -3962.62%

Expenses

Total expenses

$11.66M
VTAK annual total expenses is $11.66 million

Operating expenses

$11.62M
VTAK annual total operating expenses is $11.62 million

Cost of goods sold

$42.00K
VTAK annual cost of goods sold is $42.00 thousand

Selling, general & administrative expenses

$11.35M
VTAK annual SGA is $11.35 million

Depreciation and amortization

$2.11M
VTAK annual depreciation & amortization is $2.11 million

Interest expense

$91.00K
VTAK annual interest expense is $91.00 thousand

Income tax

$3.14M
VTAK annual income tax is $3.14 million

EBIT & EBITDA

EBIT

-$13.41M
VTAK annual earnings before interest & taxes is -$13.41 million

EBITDA

-$11.30M
VTAK annual EBITDA is -$11.30 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$27.77M
VTAK annual total assets is $27.77 million

Non current assets

$24.48M
VTAK annual long term assets is $24.48 million

Current assets

$3.29M
VTAK annual total current assets is $3.29 million

Cash and cash equivalents

$2.87M
VTAK annual cash & cash equivalents is $2.87 million

Accounts receivable

$70.00K
VTAK annual accounts receivable is $70.00 thousand

Inventory

$33.00K
VTAK annual inventory is $33.00 thousand

Liabilities

Total liabilities

$16.01M
VTAK annual total liabilities is $16.01 million

Long term liabilities

$13.93M
VTAK annual total long term liabilities is $13.93 million

Current liabilities

$2.08M
VTAK annual total current liabilities is $2.08 million

Accounts payable

$230.00K
VTAK annual accounts payable is $230.00 thousand

Debt

Total debt

$1.79M
VTAK annual total debt is $1.79 million

Total debt 1-year change

+380.65%
VTAK annual total debt is up +380.65% year-on-year

Long term debt

$1.51M
VTAK annual long term debt is $1.51 million

Short term debt

$275.00K
VTAK annual short term debt is $275.00 thousand

Equity & Capital

Shareholders equity

$11.76M
VTAK annual stockholders equity is $11.76 million

Book value

$11.76M
VTAK annual book value is $11.76 million

Retained earnings

-$292.35M
VTAK annual retained earnings is -$292.35 million

Working capital

$1.21M
VTAK annual working capital is $1.21 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$9.27M
VTAK annual cash flow from operations is -$9.27 million

Cash from operations 1-year change

+55.04%
VTAK annual cash flow from operations is up +55.04% year-on-year

Cash from investing

-$67.00K
VTAK annual cash flow from investing activities is -$67.00 thousand

Cash from investing 1-year change

-9.84%
VTAK annual cash flow from investing activities is down -9.84% year-on-year

Cash from financing

$8.65M
VTAK annual cash flow from financing activities is $8.65 million

Cash from financing 1-year change

+3.1%
VTAK annual cash flow from financing activities is up +3.1% year-on-year

CAPEX

CAPEX

$67.00K
VTAK annual capital expenditures is $67.00 thousand

CAPEX 1-year change

-11.84%
VTAK annual capital expenditures is down -11.84% year-on-year

Free Cash Flow

Free cash flow

-$9.34M
VTAK annual free cash flow is -$9.34 million

Free cash flow 1-year change

+54.88%
VTAK annual free cash flow is up +54.88% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

90.00%
VTAK annual gross profit margin is 90.00%

Operating margin

-2676.90%
VTAK annual operating profit margin is -2676.90%

Net margin

-3962.62%
VTAK annual net profit margin is -3962.62%

ROA & ROE

ROA

-56.89%
VTAK annual return on assets is -56.89%

ROE

-101.02%
VTAK annual return on equity is -101.02%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
VTAK price to earnings ratio value is unknown

PE ratio Sector rank

-
VTAK price to earnings ratio is unknown

PB Ratio

PB ratio

0.22
VTAK price to book ratio is 0.22

PB ratio Sector rank

20.31%
VTAK price to book ratio is higher than 20.31% of companies in Healthcare sector

PS Ratio

PS ratio

6.30
VTAK price to sales ratio is 6.30

PS ratio Sector rank

71.28%
VTAK price to sales ratio is higher than 71.28% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.56M
VTAK enterprise value is $1.56 million

Enterprise value Sector rank

15.61%
VTAK enterprise value is higher than 15.61% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.16
VTAK EV/EBITDA is -0.16

EV/EBITDA Sector rank

58.82%
VTAK EV/EBITDA is higher than 58.82% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.58
VTAK annual current ratio is 1.58

Quick ratio

1.56
VTAK annual quick ratio is 1.56

Leverage

Debt to equity

0.14
VTAK annual debt to equity ratio is 0.14

Interest coverage ratio

-147.37
VTAK annual interest coverage ratio is -147.37

Risk & Stability

Piotroski F-Score

2
VTAK piotroski f-score is 2

Altman Z-Score

-16.17
VTAK altman z-score is -16.17

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

TIVC logo
Tivic Health Systems (TIVC)
ARTL logo
Artelo Biosciences (ARTL)
EIGR logo
Eiger BioPharmaceuticals (EIGR)
MTNB logo
Matinas BioPharma Holdings (MTNB)
ONVO logo
Organovo Holdings (ONVO)
VERO logo
Venus Concept (VERO)
ENSC logo
Ensysce Biosciences (ENSC)
THAR logo
Tharimmune (THAR)
BBLG logo
Bone Biologics (BBLG)
  • What is the ticker symbol for Catheter Precision?
  • Does Catheter Precision pay dividends?
  • What sector is Catheter Precision in?
  • What industry is Catheter Precision in?
  • What country is Catheter Precision based in?
  • When did Catheter Precision go public?
  • Is Catheter Precision in the S&P 500?
  • Is Catheter Precision in the NASDAQ 100?
  • Is Catheter Precision in the Dow Jones?
  • When was Catheter Precision's last earnings report?
  • When does Catheter Precision report earnings?
  • Should I buy Catheter Precision stock now?

What is the ticker symbol for Catheter Precision?

The ticker symbol for Catheter Precision is NYSE American:VTAK

Does Catheter Precision pay dividends?

No, Catheter Precision does not pay dividends

What sector is Catheter Precision in?

Catheter Precision is in the Healthcare sector

What industry is Catheter Precision in?

Catheter Precision is in the Medical Devices industry

What country is Catheter Precision based in?

Catheter Precision is headquartered in United States

When did Catheter Precision go public?

Catheter Precision's initial public offering (IPO) was on September 27, 2018

Is Catheter Precision in the S&P 500?

No, Catheter Precision is not included in the S&P 500 index

Is Catheter Precision in the NASDAQ 100?

No, Catheter Precision is not included in the NASDAQ 100 index

Is Catheter Precision in the Dow Jones?

No, Catheter Precision is not included in the Dow Jones index

When was Catheter Precision's last earnings report?

Catheter Precision's most recent earnings report was on Nov 29, 2019

When does Catheter Precision report earnings?

The date for Catheter Precision's next earnings report has not been announced yet

Should I buy Catheter Precision stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page